As reviewed in [54], a loss of syndecan-1 is associated with a decrease in E-cadherin expression, which can alter the adhesion and migration properties in some tumors; this loss of syndecan-1 is associated with accelerated tumor progression and poor prognosis in head and neck, lung, and colorectal cancer. Here, SDC1 is linked to colorectal cancer.